US 11,890,317 B2
Cell-protecting composition containing cyclo histidine-proline as active ingredient
Hoe-Yune Jung, Pohang-si (KR); Heon-Jong Lee, Incheon (KR); Jong-Su Jeon, Pohang-si (KR); Yon-Su Kim, Seoul (KR); Seung-Hee Yang, Seoul (KR); Yong-Chul Kim, Seoul (KR); Jong-Joo Moon, Seoul (KR); Hwan-Soo Yoo, Cheongju-si (KR); and Kyeong-Mi Choi, Cheongju-si (KR)
Assigned to NovMetaPharma Co., Ltd., Seoul (KR)
Filed by NovMetaPharma Co., Ltd., Seoul (KR)
Filed on Jul. 1, 2022, as Appl. No. 17/856,729.
Application 17/172,879 is a division of application No. 16/316,595, granted, now 10,918,693, issued on Feb. 16, 2021, previously published as PCT/KR2017/007518, filed on Jul. 13, 2017.
Application 17/856,729 is a continuation in part of application No. 17/172,879, filed on Feb. 10, 2021, granted, now 11,433,114, issued on Sep. 6, 2022.
Claims priority of application No. 10-2016-0088751 (KR), filed on Jul. 13, 2016; and application No. 10-2017-0088341 (KR), filed on Jul. 12, 2017.
Prior Publication US 2022/0331396 A1, Oct. 20, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/05 (2006.01); A61K 38/12 (2006.01); A23L 33/18 (2016.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); C07K 5/12 (2006.01); A23L 33/00 (2016.01); A61P 1/16 (2006.01)
CPC A61K 38/12 (2013.01) [A23L 33/00 (2016.08); A23L 33/18 (2016.08); A61K 38/05 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07K 5/12 (2013.01); A23V 2002/00 (2013.01); A23V 2200/308 (2013.01); A23V 2250/55 (2013.01); A61P 1/16 (2018.01)] 14 Claims
 
1. A method of treating a subject suffering from a kidney disease or kidney damage,
said method comprising administering an effective amount of a composition to the subject,
wherein the composition comprises cyclo-histidine-proline (CHP) or a pharmaceutically acceptable salt thereof, as an active ingredient, and
wherein the kidney disease or kidney damage excludes acute renal failure.